With Recent Acquisitions, NewBridge Global Ventures Creates Impressive Offering
Tony Deyes
November 1st, 2018
News, Top News
NewBridge Global Ventures, Inc. (OTCQB: NBGV) is a US public company acquiring and currently operating a vertically integrated portfolio of California cannabis and hemp companies.
Its vertical structure includes cannabis cultivation, manufacturing, distribution and consulting services. It is currently licensed to cultivate, manufacture, and distribute both medical and recreational cannabis in the California market, the largest in the world.
In July, 2018, Newbridge Global Ventures announced the acquisition of six cannabis related companies in northern California, and as a result, by Q1 2019, expects to have fully licensed and compliant facilities for a tissue culture lab and cloning nursery, indoor & outdoor cultivation, oil extraction and distribution. The founders of the acquired companies – pioneers in the California cannabis industry – have been given senior executive operation management positions and membership on the Board of Directors, and key staff has been retained, bringing their expertise and experience to the team.
Impressive, Diverse Portfolio
Roots of Caly DBA Roots Nursery is a quality indoor nursery with the capacity to produce up to 65,000 clones per month. It is currently building a state-of-the-art 6,000 square foot facility on company-owned property located in Oakland’s “green zone”, expected to be completed by the end of 2018. The facility will supply high quality and proprietary genetics to both its own operations and other cultivators throughout California.
The Bay Clonery is building-out a 5,000 square foot company-owned facility inside a 45,000 square foot compound in Santa Rosa, California which will be completed later this year. This facility will contain a tissue culture lab and its nursery will have the capacity to produce more than 100,000 clones per month. By preserving the genetics of proprietary cannabis strains and collaborating with breeders and seed banks, The Bay Clonery plans to create and maintain a genetic clone library, enabling the genetic testing of strains that show promise. By identifying strains that have higher percentages of either THC or CBD, a whole new segment of products may develop which could hold significant medical promise.
5Leaf Extraction is positioning itself to be a leading cannabis and industrial hemp manufacturer of Full Spectrum Oils (“FSO”) distillate, as well as THC isolates and strain specific terpenes for local craft cannabis cultivators, recreational and medical brands, and potential R&D by pharmaceutical companies. 5Leaf is headed by its President, Dr. John MacKay, a pioneer in CO2 supercritical extraction with over 20 years of experience in extraction techniques and equipment development & manufacturing. Two separate build-outs are in progress, including a company-owned 10,500 square foot extraction facility in Oakland, and a company-owned 6,500 square foot warehouse inside a 45,000 square foot compound in Santa Rosa, California. Upon completion, 5Leaf should have the capacity to process more than 2,000 lbs. of biomass per day yielding an estimated 200 lbs. of FSO.
Mad Creek Farm is a 27-acre company-owned farm in Mendocino, California. Phase one will host two state of the art indoor greenhouses totaling 10,000 square feet, designed to produce 5,000 pounds of biomass per year. Mad Creek should be fully operational in Q2 of 2019.
GENUS Management & Consulting Group is an Oakland-based management services company integral to the operations of 5Leaf, Roots Nursery, Mad Creek Farm and The Bay Clonery. With over 45 years of collective experience building successful and compliant California cannabis companies, it is uniquely positioned to provide consulting services to cultivators, processors, and retail brands. Its services include compliance, licensing, permitting, budgeting, brand/product development, infrastructure development, insurance and any other aspect of business development.
G
reen Thumb Distributors will operate as the company’s compliant cannabis distribution company. With 45 years of combined experience, its leadership team has built relationships with industry leaders and pioneers. The company will provide distribution services to cannabis & hemp entrepreneurs who may not want or be able to bear the high costs of regulations. Green Thumb will package, label, and distribute products for cultivators, manufacturers and retailers who, by law, require third party distribution services.
Elevated Education produces online and in-person modules designed to educate physicians, clinicians, healthcare insurers, public servants, educators, and cannabis industry professionals worldwide on a range of subjects, such as the human endocannabinoid system, pharmacology, and effective clinical applications for medical marijuana.
On October 25, 2018, Dr. John MacKay was appointed as president of 5Leaf Extraction and Elevated Education. Dr. MacKay earned his B.A. in Chemistry at St. Lawrence University, and his Ph.D. at the University of Vermont, focusing on Inorganic Chemistry and on the synthesis of cancer fighting compounds, and is recognized as a scientific expert in sub and supercritical fluid for chromatography and extraction within the botanical space. At 5Leaf, he will focus on maximizing productivity of work flow for botanical and medical cannabis, and oversee the build-out of both Newbridge refineries, including quality assurance and control, to ensure both are in full compliance with state and federal regulations. He will also be involved in developing the curriculum for Elevated Education.
With an experienced management team and a focus on compliance, industry best practices, standardization, and corporate governance, NewBridge Global Ventures is positioned for growth in California’s enormous legal cannabis market and the industrial hemp Industry.
For further information, please visit their website: https://www.newbridgegv.com/
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Tony Deyes
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Watch CFN Media’s exclusive three part interview with Paul Rosen, one of the most active and diversified investors in the emerging cannabis industry. Paul gives his insights on the global cannabis industry and discusses his new endeavors. Become a CFN Media Client Paul Rosen is a noted career entrepreneur and management consultant. Over the last […]
JWC is a Licensed Producer under the ACMPR with the goal of helping patients by providing clean, consistent medical cannabis products.
Xphyto Therapeutics Corp. was created to bridge the gap between traditional cannabis-based medicine and modern scientific approaches to therapeutic validation.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
